Punctal Plug Study to Determine the Safety and Retention Times of Various Lengths of Canalicular Stents in Volunteers

NCT ID: NCT00743249

Last Updated: 2013-04-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-10-31

Study Completion Date

2009-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to determine the safety and retention times of two different lengths (10 mm and 20 mm) of the MINI MONOKA canicular stent when inserted in the eye for up to three months in subjects with or without dry eye.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study consisted of 6 visits conducted over a period of 3 months. At Visit 1 (Day 0), the canalicular stent was inserted. If the stent insertion failed, the subject was rescheduled for insertion at the Day 2 visit. If the stent insertion was not successfully completed by the end of the Day 2 visit, the subject was discontinued from the study. Any subject who had the stent inserted but lost the stent (noticed or unnoticed) after the Day 2 Visit was considered to have completed the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Dry Eye

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Canalicular stent, 10 mm

MINI MONOKA canalicular stent (tube), 10 mm, inserted in the lower lacrimal canaliculus (tear duct) of one eye for up to 3 months

Group Type EXPERIMENTAL

MINI MONOKA canalicular stent, 10 mm

Intervention Type DEVICE

40 mm hollow intubation stent composed of a silicon tube and an oval collarette head (plug), cut to 10 mm length

Canalicular stent, 20 mm

MINI MONOKA canalicular stent (tube), 20 mm, inserted in the lower lacrimal canaliculus (tear duct) of one eye for up to 3 months

Group Type EXPERIMENTAL

MINI MONOKA canalicular stent, 20 mm

Intervention Type DEVICE

40 mm hollow intubation stent composed of a silicon tube and an oval collarette head (plug), cut to 20 mm length

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MINI MONOKA canalicular stent, 10 mm

40 mm hollow intubation stent composed of a silicon tube and an oval collarette head (plug), cut to 10 mm length

Intervention Type DEVICE

MINI MONOKA canalicular stent, 20 mm

40 mm hollow intubation stent composed of a silicon tube and an oval collarette head (plug), cut to 20 mm length

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MINI MONOKA MINI MONOKA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sign Informed Consent.
* With or without dry eye.
* Willing to discontinue contact lenses during the study.

Exclusion Criteria

* Chronic, recurrent, or severe inflammatory eye disease.
* Ocular trauma within the past 6 months.
* Ocular hypertension or glaucoma.
* History of punctal plug/canalicular stent insertion.
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Theresa A Landry, Ph.D.

Role: STUDY_DIRECTOR

Alcon Research

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C-07-23

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Partial Lacrimal Punctual Occlusion
NCT00802399 COMPLETED NA